Clinical trial
Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts…
NCT00497926 · Talaris Therapeutics Inc., Industry · Terminated
Key facts
| NCT number | NCT00497926 |
|---|---|
| Title | Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion |
| Official title | Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion |
| Lead sponsor | Talaris Therapeutics Inc., Industry |
| Collaborators | Northwestern University Regenerex, LLC Duke University |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Failure |
| Intervention type | Biological |
| Interventions | Enriched Hematopoietic Stem Cell Infusion |
| Enrollment | 37 |
| Start date | Mar 1, 2008 |
| Primary completion | Mar 1, 2023 |
| Completion | Apr 1, 2023 |
| First posted | Jul 9, 2007 |
| Last update posted | Oct 11, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: